PHARMALOGOS LIMITED

Company number 08216089 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£75k -£50k -£25k £0 £25k £50k £75k £100k £125k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2018: £104,126 Total assets 2019: £79,816 Total assets 2020: £79,356 Total assets 2021: £60,981 Total assets 2022: £57,760 Total assets 2023: £71,002 Total assets 2024: £76,198 Total assets 2025: £96,101 Total assets Net assets 2016: £27,494 Net assets 2017: £77,242 Net assets 2018: £87,115 Net assets 2019: £72,527 Net assets 2020: £52,243 Net assets 2021: £31,259 Net assets 2022: £24,600 Net assets 2023: £37,996 Net assets 2024: £36,844 Net assets 2025: £43,524 Net assets Total liabilities 2016: -£7,345 Total liabilities 2017: -£31,678 Total liabilities 2018: -£16,063 Total liabilities 2019: -£5,311 Total liabilities 2020: -£25,396 Total liabilities 2021: -£28,189 Total liabilities 2022: -£31,680 Total liabilities 2023: -£31,536 Total liabilities 2024: -£37,648 Total liabilities 2025: -£51,137 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 0 0 0 1 2024 2025 2024: 0 2025: 0

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 13 years

Latest accounts (2025-09-30): Audit exempt (accountant's report).

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-09-30 £96,101 -£51,137 £43,524 0
2024-09-30 £76,198 -£37,648 £36,844 0
2023-09-30 £71,002 -£31,536 £37,996
2022-09-30 £57,760 -£31,680 £24,600
2021-09-30 £60,981 -£28,189 £31,259
2020-09-30 £79,356 -£25,396 £52,243
2019-09-30 £79,816 -£5,311 £72,527
2018-09-30 £104,126 -£16,063 £87,115
2017-09-30 -£31,678 £77,242 £83,096
2016-09-30 -£7,345 £27,494 £28,288
2015-09-30 -£1,101 £33,121 £24,127
2014-09-30 -£20,417 £49,997 £60,309
2013-09-30 £26,209 -£16,895 £19,239 £21,994

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.